Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > DXCM DexCom > Financial Statement > Income statement
DXCM DexCom
118.110
+0.080+0.07%
Pre Mkt Price
118.1100.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Total revenue
18.36% 769.6M 16.99% 696.2M 24.51% 628.8M 27.08% 2.45B
Operating revenue
18.36% 769.6M 16.99% 696.2M 24.51% 628.8M 27.08% 2.45B
Cost of revenue
35.46% 275.4M 38.60% 246.7M 43.20% 230.7M 18.78% 768M
Gross profit
10.58% 494.2M 7.77% 449.5M 15.76% 398.1M 31.28% 1.68B
Operating expense
5.51% 346.7M 17.84% 372.5M 19.73% 356.8M 44.27% 1.41B
Selling and administrative expenses
17.42% 234.6M 33.10% 248.9M 17.13% 220.9M 30.58% 810.5M
Research and development costs
-14.36% 110.3M -5.73% 121.7M 24.22% 135.9M 67.88% 604.2M
Depreciation amortization depletion
-- 1.8M -- 1.9M -- -- -- --
-Depreciation and amortization
-- 1.8M -- 1.9M -- -- -- --
Operating profit
24.68% 147.5M -23.76% 77M -10.02% 41.3M -11.25% 265.8M
Net non-operating interest income expense
94.82% -1.3M 93.00% -1.7M 78.14% -5.4M -48.69% -102M
Non-operating interest income
-- 3.3M 233.33% 3M -- -- -- --
Non-operating interest expense
-81.67% 4.6M -81.35% 4.7M -78.23% 5.4M 20.43% 102M
Other net income (expense)
200K 271.19% 10.1M
Earnings from equity interest
-- 0 -- 0 -- 200K -- 11.6M
Special income (charges)
-- -- -- -- -- -- 74.58% -1.5M
-Less:Other special charges
-- -- -- -- -- -- -74.58% 1.5M
Income before tax
61.19% 146.2M -1.83% 75.3M 70.28% 36.1M -22.71% 173.9M
Income tax
127.27% 45M 76.81% 24.4M -220.42% -61.2M 107.15% 19.2M
Net income
42.74% 101.2M -19.08% 50.9M 141.44% 97.3M -68.66% 154.7M
Net income continuous Operations
42.74% 101.2M -19.08% 50.9M 141.44% 97.3M -68.66% 154.7M
Minority interest income
Net income attributable to the parent company
42.74% 101.2M -19.08% 50.9M 141.44% 97.3M -68.66% 154.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.74% 101.2M -19.08% 50.9M 141.44% 97.3M -68.66% 154.7M
Basic earnings per share
42.47% 0.26 -20.00% 0.13 138.10% 0.25 -69.41% 0.4
Diluted earnings per share
35.21% 0.24 -23.81% 0.12 126.83% 0.2325 -69.37% 0.3875
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
------Unqualified Opinion

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
CEO: --
Market: NASDAQ
Listing Date: 04/14/2005
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist